Tang Capital Acquisition, a special purpose acquisition company (SPAC) created by Tang Capital to focus on clinical‑stage biotechnology firms, has formally filed with the SEC to raise up to $75 million through its initial public offering. The filing, submitted on …
SPAC and Sector-Driven IPOs Surge as Biotech, Climate Tech, and Data Centers Lead Q4 Filings
New SPACs and sector‑focused offerings dominate the latest IPO wave, with Tang Capital Acquisition seeking $75 million to fund development‑stage biopharma, while Allarity Acquisition trimmed its unit count to target an $80 million biotech raise. Climate‑tech‑focused Pine Tree Acquisition priced …